If nausea onset coincides with 5-amino-1MQ introduction but tirzepatide dose was stable for 4+ weeks prior, the new compound is the likely culprit
Contact your GP or prescribing clinician if you experience : Severe or worsening fatigue that significantly impairs daily activities or persists beyond several weeks of treatment Extreme weakness or inability to perform usual tasks Dizziness or fainting , particularly on standing, which may indicate dehydration or blood pressure changes Persistent nausea or vomiting preventing adequate food or fluid intake Signs of dehydration : dark urine, reduced urination, dry mouth, confusion Chest pain, palpitations, or breathlessness accompanying tiredness Mood changes , including low mood or depression, which can manifest as fatigue Right upper abdominal pain, fever or yellowing of the skin/eyes , which could indicate gallbladder problems (GLP-1 medications may increase gallstone risk) For urgent but non-emergency concerns, you can contact NHS 111 for advice
This article is for informational purposes only and does not constitute medical advice
At Revive Wellness and Rejuvenation, we are committed to helping you achieve long-lasting relief through safe, effective, and non-surgical treatment options
This makes BPC-157 a highly effective supplement for tissue repair and regeneration
